Furthermore, upregulated levels of miR-559 can inhibit the growth of HCC, drug resistance, and formation of new blood vessels by reducing the expression of PARD3 (Wang et al., 2022). This evidence concerns the gene PARD3 and hepatocellular carcinoma.